1. Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment. (1st May 2016) Authors: Wohl, David; Oka, Shinichi; Clumeck, Nathan; Clarke, Amanda; Brinson, Cynthia; Stephens, Jeffrey; Tashima, Karen; Arribas, Jose R.; Rashbaum, Bruce; Cheret, Antoine; Brunetta, Jason; Mussini, Cristina; Tebas, Pablo; Sax, Paul E.; Cheng, Andrew; Zhong, Lijie; Callebaut, Christian; Das, Moupali; Fo... Journal: Journal of acquired immune deficiency syndromes Issue: Volume 72:Number 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B–Coinfected Adults. (1st November 2016) Authors: Gallant, Joel; Brunetta, Jason; Crofoot, Gordon; Benson, Paul; Mills, Anthony; Brinson, Cynthia; Oka, Shinichi; Cheng, Andrew; Garner, Will; Fordyce, Marshall; Das, Moupali; McCallister, Scott Journal: Journal of acquired immune deficiency syndromes Issue: Volume 73:Number 3(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P045 Switching from boosted atazanavir (ATV) plus FTC/TDF to a TAF-based single tablet regimen (STR): week 48 data in virologically suppressed adults. (30th June 2016) Authors: Orkin, Chloe; Rjinders, Bart; Stephan, Christoph; McKellar, Mehri; Kiertiburanakul, Sasisopin; Arribas, Jose; Murphy, Daniel; Bloch, Mark; Liu, YaPei; Fordyce, Marshall; Yau, Stuart; McCallister, Scott Journal: Sexually transmitted infections Issue: Volume 92(2016)Supplement 1 Page Start: A34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P099 Renal Safety of Tenofovir Alafenamide in Patients at High Risk of Kidney Disease. (30th June 2016) Authors: Waters, Laura; Wohl, David; Thalme, Anders; Finlayson, Robert; Oka, Shinichi; Das, Moupali; Yau, Stuart; Fordyce, Marshall Journal: Sexually transmitted infections Issue: Volume 92(2016)Supplement 1 Page Start: A53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P99 Renal and bone safety of tenofovir alafenamide vs tenofovir disoproxil fumarate. (18th May 2015) Authors: Post, Frank; Sax, Paul; Saag, Michael; Yin, Michael; Oka, Shinichi; Koenig, Ellen; Trottier, Benoit; Andrade, Jaime; Cao, Huyen; Fordyce, Marshall Journal: Sexually transmitted infections Issue: Volume 91(2015)Supplement 1 Page Start: A48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pharmacokinetics of Co-Formulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate After Switch From Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Healthy Subjects. (1st July 2016) Authors: Ramanathan, Srini; Custodio, Joseph M.; Wei, Xuelian; Wang, Hui; Fordyce, Marshall; Dave, Ami; Ling, Kah Hiing J.; Szwarcberg, Javier; Kearney, Brian P. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 72:Number 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Rare emergence of drug resistance in HIV-1 treatment -naïve patients after 48 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide. Issue 2 (3rd March 2016) Authors: Margot, Nicolas A.; Kitrinos, Kathryn M.; Fordyce, Marshall; McCallister, Scott; Miller, Michael D.; Callebaut, Christian Journal: HIV clinical trials Issue: Volume 17:Issue 2(2016) Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗